EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H16ClF3N4O3 |
| Net Charge | 0 |
| Average Mass | 464.831 |
| Monoisotopic Mass | 464.08630 |
| SMILES | CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 |
| InChI | InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31) |
| InChIKey | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine. ferroptosis inducer Any substance that induces or promotes ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms. anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. tyrosine kinase inhibitor Any protein kinase inhibitor that interferes with the action of tyrosine kinase. |
| Applications: | angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| sorafenib (CHEBI:50924) has role angiogenesis inhibitor (CHEBI:48422) |
| sorafenib (CHEBI:50924) has role anticoronaviral agent (CHEBI:149553) |
| sorafenib (CHEBI:50924) has role antineoplastic agent (CHEBI:35610) |
| sorafenib (CHEBI:50924) has role EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor (CHEBI:50925) |
| sorafenib (CHEBI:50924) has role ferroptosis inducer (CHEBI:173085) |
| sorafenib (CHEBI:50924) has role tyrosine kinase inhibitor (CHEBI:38637) |
| sorafenib (CHEBI:50924) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| sorafenib (CHEBI:50924) is a aromatic ether (CHEBI:35618) |
| sorafenib (CHEBI:50924) is a monochlorobenzenes (CHEBI:83403) |
| sorafenib (CHEBI:50924) is a phenylureas (CHEBI:134043) |
| sorafenib (CHEBI:50924) is a pyridinecarboxamide (CHEBI:25529) |
| Incoming Relation(s) |
| sorafenib tosylate (CHEBI:50928) has part sorafenib (CHEBI:50924) |
| IUPAC Name |
|---|
| 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide |
| INNs | Source |
|---|---|
| sorafenib | WHO MedNet |
| sorafénib | WHO MedNet |
| sorafenibum | WHO MedNet |
| sorafenib | WHO MedNet |
| Synonyms | Source |
|---|---|
| 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide | ChemIDplus |
| N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea | ChemIDplus |
| Citations |
|---|